The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
Plasma Ceramides, Mediterranean Diet, and Incident Cardiovascular Disease in the PREDIMED Trial (Prevención con Dieta Mediterránea)
Open accessAbstract
Background: Although in vitro studies and investigations in animal models and small clinical populations have suggested that ceramides may represent an intermediate link between overnutrition and certain pathological mechanisms underlying cardiovascular disease (CVD), no prospective studies have investigated the association between plasma ceramides and risk of CVD. Methods: The study population consisted of 980 participants from the PREDIMED trial (Prevención con Dieta Mediterránea), including 230 incident cases of CVD and 787 randomly selected participants at baseline (including 37 overlapping cases) followed for ≤7.4 years. Participants were randomized to a Mediterranean diet supplemented with extra virgin olive oil, a Mediterranean diet supplemented with nuts, or a control diet. Plasma ceramide concentrations were measured on a liquid chromatography tandem mass spectrometry metabolomics platform. The primary outcome was a composite of nonfatal acute myocardial infarction, nonfatal stroke, or cardiovascular death. Hazard ratios were estimated with weighted Cox regression models using Barlow weights to account for the case-cohort design. Results: The multivariable hazard ratios (HR) and 95% confidence intervals (CIs) comparing the extreme quartiles of plasma concentrations of C16:0, C22:0, C24:0, and C24:1 ceramides were 2.39 (1.49–3.83, P trend <0.001), 1.91 (1.21–3.01, P trend =0.003), 1.97 (1.21–3.20, P trend =0.004), and 1.73 (1.09–2.74, P trend =0.011), respectively. The ceramide score, calculated as a weighted sum of concentrations of four ceramides, was associated with a 2.18-fold higher risk of CVD across extreme quartiles (HR, 2.18; 95% CI, 1.36–3.49; P trend <0.001). The association between baseline ceramide score and incident CVD varied significantly by treatment groups ( P interaction =0.008). Participants with a higher ceramide score and assigned to either of the 2 active intervention arms of the trial showed similar CVD risk to those with a lower ceramide score, whereas participants with a higher ceramide score and assigned to the control arm presented significantly higher CVD risk. Changes in ceramide concentration were not significantly different between Mediterranean diet and control groups during the first year of follow-up. Conclusions: Our study documented a novel positive association between baseline plasma ceramide concentrations and incident CVD. In addition, a Mediterranean dietary intervention may mitigate potential deleterious effects of elevated plasma ceramide concentrations on CVD. Clinical Trial Registration: URL: http://www.isrctn.com . Unique identifier: ISRCTN35739639.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is well known that aberrant accumulation of ceramides, that frequently occurs because of excess saturated fat consumption, may lead to impaired cellular function, including impaired insulin function [55], while the MD has a favorable impact on CVD by diminishing ceramide concentration.”
From Mediterranean Diet as an Antioxidant: The Impact on Metabolic Health and Overall Wellbeing (2021) · cites this paper as [55]
In the citing paper
“It is well known that aberrant accumulation of ceramides, that frequently occurs because of excess saturated fat consumption, may lead to impaired cellular function, including impaired insulin function [55], while the MD has a favorable impact on CVD by diminishing ceramide concentration.”
From Mediterranean Diet as an Antioxidant: The Impact on Metabolic Health and Overall Wellbeing (2021) · cites this paper as [55]
In the citing paper
“The unsaturated fatty acids that are highly represented in the MD and especially in the extra virgin olive oil have been demonstrated, according to the PREDIMED Trial, to contribute to diminished ceramide accumulation and therefore to confer a cardioprotective effect.”
From Mediterranean Diet as an Antioxidant: The Impact on Metabolic Health and Overall Wellbeing (2021) · cites this paper as [55]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
RETRACTED: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet
Estruch, R., Ros, E., Salas-Salvadó, J., Covas, M.-I., Corella, D., Arós, F., Gómez-Gracia, E., Ruiz-Gutiérrez, V., Fiol, M., Lapetra, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1200303 · Cited by 4,257
Self-citationRetractedEstruch, R., Ros, E., Salas-Salvadó, J., Covas, M.-I., Corella, D., Arós, F., Gómez-Gracia, E., Ruiz-Gutiérrez, V., Fiol, M., Lapetra, J., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmc1806491 · Cited by 1,008
Self-citationRetractedZhang, Q., Wang, C., Zheng, M., Li, Y., Li, J., Zhang, L., Shang, X., & Yan, C. (2014) · Cerebrovascular Diseases · doi:10.1159/000369778 · Cited by 11,609
Pencina, M. J., D' Agostino, R. B., D' Agostino, R. B., & Vasan, R. S. (2008) · Statistics in Medicine · doi:10.1002/sim.2929 · Cited by 6,493
Antman, E. M., Bassand, J., Klein, W. W., Ohman, M. E., Sendón, J. L. L., Rydén, L., Simoons, M. L., & Tendera, M. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00804-4 · Cited by 4,824
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
Hemphill, J. C., Greenberg, S. M., Anderson, C. S., Becker, K. J., Bendok, B. R., Cushman, M., Fung, G. L., Goldstein, J. N., Macdonald, R. L., Mitchell, P. H., et al. (2015) · Stroke · doi:10.1161/str.0000000000000069 · Cited by 4,053
Dietary pattern analysis: a new direction in nutritional epidemiology
Hu, F. B. (2002) · Current Opinion in Lipidology · doi:10.1097/00041433-200202000-00002 · Cited by 4,029
Self-citationEstruch, R., Ros, E., Salas-Salvadó, J., Covas, M.-I., Corella, D., Arós, F., Gómez-Gracia, E., Ruiz-Gutiérrez, V., Fiol, M., Lapetra, J., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1800389 · Cited by 3,616
Self-citationMetabolite profiles and the risk of developing diabetes
Wang, T. J., Larson, M. G., Vasan, R. S., Cheng, S., Rhee, E. P., McCabe, E., Lewis, G. D., Fox, C. S., Jacques, P. F., Fernandez, C., et al. (2011) · Nature Medicine · doi:10.1038/nm.2307 · Cited by 3,143
Self-citationGuidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008
The European Stroke Organisation (ESO) Executive Committee and the ESO Writing Committee (2008) · Cerebrovascular Diseases · doi:10.1159/000131083 · Cited by 2,504
Flagged first, then by citations
Research works printed but not linked: 1
- 10.2337/db08-1228 · DOI
Cited by
Sorted by citations
The Mediterranean Diet and Cardiovascular Health: A Critical Review
Martínez-González, M. A., Gea, A., & Ruiz-Canela, M. (2019) · Circulation Research · doi:10.1161/circresaha.118.313348 · Cited by 878
Self-citationSphingolipids in metabolic disease: The good, the bad, and the unknown
Green, C. D., Maceyka, M. W., Cowart, L. A., & Spiegel, S. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.06.006 · Cited by 343
Hilvo, M., Meikle, P. J., Pedersen, E. R., Tell, G. S., Dhar, I., Brenner, H., Schöttker, B., Lääperi, M., Kauhanen, D., Koistinen, K. M., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz387 · Cited by 312
Mediterranean Diet as an Antioxidant: The Impact on Metabolic Health and Overall Wellbeing
Gantenbein, K. V., & Kanaka-Gantenbein, C. (2021) · Nutrients · doi:10.3390/nu13061951 · Cited by 288
Metabolic and Vascular Effect of the Mediterranean Diet
Tuttolomondo, A., Simonetta, I., Daidone, M., Mogavero, A., Ortello, A., & Pinto, A. V. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194716 · Cited by 283
Benefits of the Mediterranean diet: Epidemiological and molecular aspects
Serra‐Majem, L., Román‐Viñas, B., Sánchez‐Villegas, A., Guasch‐Ferré, M., Corella, D., & Vecchia, C. L. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2019.06.001 · Cited by 259
Self-citationMeeusen, J. W., Donato, L. J., Bryant, S. C., Baudhuin, L. M., Berger, P. B., & Jaffe, A. S. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.311199 · Cited by 233
Gaforio, J. J., Visioli, F., Alarcón-de-la-Lastra, C., Castañer, O., Delgado-Rodríguez, M., Fitó, M., Hernández, A. F., Huertas, J. R., Martínez-González, M. A., Menendez, J. A., et al. (2019) · Nutrients · doi:10.3390/nu11092039 · Cited by 187
Self-citationCould Ceramides Become the New Cholesterol?
Summers, S. A. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2017.12.003 · Cited by 184
Ceramide Remodeling and Risk of Cardiovascular Events and Mortality
Peterson, L. R., Xanthakis, V., Duncan, M. S., Groß, S., Friedrich, N., Völzke, H., Felix, S. B., Jiang, H., Sidhu, R., Nauck, M. A., et al. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.117.007931 · Cited by 182
Genetic architecture of human plasma lipidome and its link to cardiovascular disease
Tabassum, R., Rämö, J. T., Ripatti, P., Koskela, J. T., Kurki, M., Karjalainen, J. M., Palta, P., Hassan, S., Núñez-Fontarnau, J., Kiiskinen, T., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11954-8 · Cited by 176
Metabolome Changes in Cerebral Ischemia
Shin, T. H., Lee, D. Y., Basith, S., Manavalan, B., Paik, M., Rybinnik, I., Mouradian, M. M., Ahn, J. H., & Lee, G. (2020) · Cells · doi:10.3390/cells9071630 · Cited by 171
Hadas, Y., Vincek, A. S., Youssef, E., Żak, M. M., Chepurko, E., Sultana, N., Sharkar, M. T. K., Guo, N., Komargodski, R., Kurian, A. A., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.041882 · Cited by 166
Comprehensive Metabolomic Profiling and Incident Cardiovascular Disease: A Systematic Review
Ruiz‐Canela, M., Hruby, A., Clish, C. B., Liang, L., Martínez‐González, M. Á., & Hu, F. B. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.005705 · Cited by 165
Self-citationOlive oil and prevention of chronic diseases: Summary of an International conference
Visioli, F., Franco, M., Toledo, E., Luchsinger, J. A., Willett, W. C., Hu, F. B., & Martínez‐González, M. Á. (2018) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2018.04.004 · Cited by 158
Self-citationProteomics and lipidomics in atherosclerotic cardiovascular disease risk prediction
Nurmohamed, N. S., Kraaijenhof, J. M., Mayr, M., Nicholls, S. J., Köenig, W., Catapano, A. L., & Stroes, E. S. G. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad161 · Cited by 156
Ceramides and Ceramide Scores: Clinical Applications for Cardiometabolic Risk Stratification
Hilvo, M., Vasile, V. C., Donato, L. J., Hurme, R., & Laaksonen, R. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.570628 · Cited by 147
Wu, Q., Sun, L., Hu, X., Wang, X., Xu, F., Chen, B., Liang, X., Xia, J., Wang, P., Aibara, D., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci142865 · Cited by 131
A Review of Lipidomics of Cardiovascular Disease Highlights the Importance of Isolating Lipoproteins
Ding, M., & Rexrode, K. M. (2020) · Metabolites · doi:10.3390/metabo10040163 · Cited by 135
Contribution of specific ceramides to obesity-associated metabolic diseases
Hammerschmidt, P., & Brüning, J. C. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04401-3 · Cited by 133
Metabolomics and Lipidomics of Ischemic Stroke
Au, A. (2018) · Advances in clinical chemistry · doi:10.1016/bs.acc.2018.02.002 · Cited by 121
Understanding the Links Between Cardiovascular Disease and Parkinson's Disease
Potashkin, J., Huang, X., Becker, C., Chen, H., Foltynie, T., & Marras, C. (2019) · Movement Disorders · doi:10.1002/mds.27836 · Cited by 121
Akawi, N. A., Checa, A., Antonopoulos, A. S., Akoumianakis, I., Daskalaki, E., Kotanidis, C. P., Kondo, H., Lee, K., Yesilyurt, D., Badi, I., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.03.314 · Cited by 112
Toledo, E., Wang, D. D., Ruiz‐Canela, M., Clish, C. B., Razquín, C., Zheng, Y., Guasch‐Ferré, M., Hruby, A., Corella, D., Gómez‐Gracia, E., et al. (2017) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.116.151159 · Cited by 115
Self-citationCeramides as Mediators of Oxidative Stress and Inflammation in Cardiometabolic Disease
Gaggini, M., Ndreu, R., Michelucci, E., Rocchiccioli, S., & Vassalle, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052719 · Cited by 109
Jeong, A., Fiorito, G., Keski‐Rahkonen, P., Imboden, M., Kiss, A., Robinot, N. R., Gmuender, H., Vlaanderen, J. J., Vermeulen, R. C. H., Kyrtopoulos, S. Α., et al. (2018) · Environment International · doi:10.1016/j.envint.2018.06.025 · Cited by 105
Annevelink, C. E., Sapp, P. A., Petersen, K. S., Shearer, G. C., & Kris‐Etherton, P. M. (2023) · Journal of clinical lipidology · doi:10.1016/j.jacl.2023.07.005 · Cited by 101
Metabolomics and microbiomes as potential tools to evaluate the effects of the Mediterranean diet
Jin, Q., Black, A., Kales, S. N., Vattem, D., Ruiz-Canela, M., & Sotos-Prieto, M. (2019) · Nutrients · doi:10.3390/nu11010207 · Cited by 100
Self-citationCeramides and risk of major adverse cardiovascular events: A meta-analysis of longitudinal studies
Mantovani, A., & Dugo, C. (2020) · Journal of clinical lipidology · doi:10.1016/j.jacl.2020.01.005 · Cited by 98
Lipid Profiles and Heart Failure Risk
Wittenbecher, C., Eichelmann, F., Toledo, E., Guasch‐Ferré, M., Ruiz‐Canela, M., Li, J., Arós, F., Lee, C., Liang, L., Salas‐Salvadó, J., et al. (2020) · Circulation Research · doi:10.1161/circresaha.120.317883 · Cited by 101
Self-citationNeeland, I. J., Singh, S., McGuire, D. K., Vega, G. L., Roddy, T. P., Reilly, D. F., Castro‐Perez, J. M., Kozlitina, J., & Scherer, P. E. (2018) · Diabetologia · doi:10.1007/s00125-018-4720-1 · Cited by 98
Diet and Cardiovascular Disease: Advances and Challenges in Population-Based Studies
Pan, A., Lin, X., Hemler, E. C., & Hu, F. B. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.02.017 · Cited by 100
Self-citationSphingolipids as critical players in retinal physiology and pathology
Simón, M. V., Basu, S. K., Qaladize, B., Grambergs, R. C., Rotstein, N. P., & Mandal, N. A. (2020) · Journal of Lipid Research · doi:10.1194/jlr.tr120000972 · Cited by 97
Ke, C., Pan, C., Zhang, Y., Zhu, X., & Zhang, Y. (2019) · Metabolomics · doi:10.1007/s11306-019-1615-1 · Cited by 91
de Carvalho, L. P., Tan, S. H., Ow, G. S., Tang, Z., Ching, J., Kovalik, J., Poh, S. C., Chin, C.-T., Richards, M., Martinez, E. C., et al. (2018) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2017.12.005 · Cited by 90
Ceramide Scores Predict Cardiovascular Risk in the Community
Vasile, V. C., Meeusen, J. W., Medina‐Inojosa, J. R., Donato, L. J., Scott, C. G., Hyun, M., Vinciguerra, M., Rodeheffer, R. R., López-Jiménez, F. A., & Jaffe, A. S. (2021) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.315530 · Cited by 88
Solmi, M., Köhler, C. A., Stubbs, B., Koyanagi, A., Bortolato, B., Monaco, F., Vancampfort, D., Machado, M. O., Maes, M. H. J., Tzoulaki, I., et al. (2018) · European Journal of Clinical Investigation · doi:10.1111/eci.12982 · Cited by 92
Khayrullin, A., Krishnan, P., Martinez-Nater, L., Mendhe, B., Fulzele, S., Liu, Y., Mattison, J. A., & Hamrick, M. W. (2019) · Cells · doi:10.3390/cells8010037 · Cited by 87
Addressing the Perfect Storm: Biomarkers in Obesity and Pathophysiology of Cardiometabolic Risk
Aleksandrova, K., Mozaffarian, D., & Pischon, T. (2017) · Clinical Chemistry · doi:10.1373/clinchem.2017.275172 · Cited by 88
Sensing ceramides by CYSLTR2 and P2RY6 to aggravate atherosclerosis
Zhang, S., Lin, H., Wang, J., Rui, J., Wang, T., Cai, Z., Huang, S.-M., Gao, Y., Ma, T., Fan, R., et al. (2025) · Nature · doi:10.1038/s41586-025-08792-8 · Cited by 94
The nutritional functions of dietary sphingomyelin and its applications in food
Yang, F., & Chen, G. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1002574 · Cited by 85
Ceramide and Regulation of Vascular Tone
Cogolludo, A. L., Villamor, E., Pérez‐Vizcaíno, F., & Moreno, L. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020411 · Cited by 80
Better diet quality relates to larger brain tissue volumes
Croll, P. H., Voortman, T., Ikram, M. A., Franco, O. H., Schoufour, J. D., Bos, D., & Vernooij, M. W. (2018) · Neurology · doi:10.1212/wnl.0000000000005691 · Cited by 84
Ceramide Metabolism in Cardiovascular Disease: A Network With High Therapeutic Potential
Zietzer, A., Düsing, P., Reese, L., Nickenig, G., & Jansen, F. (2022) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.122.318048 · Cited by 78
Obesity-Related Metabolomic Profiles and Discrimination of Metabolically Unhealthy Obesity
Bagheri, M., Farzadfar, F., Qi, L., Yekaninejad, M. S., Chamari, M., Zeleznik, O. A., Kalantar, Z., Ebrahimi, Z., Sheidaie, A., Koletzko, B. V., et al. (2018) · Journal of Proteome Research · doi:10.1021/acs.jproteome.7b00802 · Cited by 82
Wang, F., Tessier, A., Liang, L., Wittenbecher, C., Haslam, D. E., Fernández-Duval, G., Eliassen, A. H., Rexrode, K. M., Tobias, D. K., Li, J., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41515-z · Cited by 72
Self-citationIntegrating bioinformatics approaches for a comprehensive interpretation of metabolomics datasets
Barupal, D. K., Fan, S., & Fiehn, O. (2018) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2018.01.010 · Cited by 71
Integrating lipidomics and genomics: emerging tools to understand cardiovascular diseases
Tabassum, R., & Ripatti, S. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03715-4 · Cited by 76
Comparative lipid profile of four edible shellfishes by UPLC-Triple TOF-MS/MS
Li, H., Song, Y., Zhang, H., Wang, X., Cong, P., Xu, J., & Xue, C. (2019) · Food Chemistry · doi:10.1016/j.foodchem.2019.125947 · Cited by 70
Changes of Metabolites in Acute Ischemic Stroke and Its Subtypes
Wang, X., Zhang, L., Sun, W., Pei, L., Tian, M., Liang, J., Liu, X., Zhang, R., Fang, H., Wu, J. W., et al. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.580929 · Cited by 69
Plasma metabolomic profiling of amino acids and polar lipids in Iranian obese adults
Bagheri, M., Djazayery, A., Farzadfar, F., Qi, L., Yekaninejad, M. S., Aslibekyan, S. W., Chamari, M., Hassani, H., Koletzko, B. V., & Uhl, O. (2019) · Lipids in Health and Disease · doi:10.1186/s12944-019-1037-0 · Cited by 71
Barlovič, D. P., Harjutsalo, V., Sandholm, N., Forsblom, C. M., Groop, P., & on behalf of the FinnDiane Study Group (2020) · Diabetologia · doi:10.1007/s00125-020-05201-9 · Cited by 65
McGurk, K. A., Keavney, B. D., & Nicolaou, A. (2021) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2021.04.021 · Cited by 68
Dietary metabolic signatures and cardiometabolic risk
Shah, R. V., Steffen, L. M., Nayor, M. G., Reis, J. P., Jacobs, D. R., Allen, N. B., Lloyd‐Jones, D. M., Meyer, K. A., Cole, J. B., Piaggi, P., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac446 · Cited by 70
Self-citationHu, F. B., Drescher, G., Trichopoulou, A., Willett, W. C., & Martínez‐González, M. Á. (2025) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2025.04.036 · Cited by 64
Self-citationChen, S., Zong, G., Wu, Q., Yun, H., Niu, Z., Zheng, H., Zeng, R., Sun, L., & Lin, X. (2021) · Diabetologia · doi:10.1007/s00125-021-05611-3 · Cited by 62
Wittenbecher, C., Cuadrat, R. R. C., Johnston, L., Eichelmann, F., Jäger, S., Kuxhaus, O., Prada, M., Fabiola Del Greco, M., Hicks, A. A., Hoffman, P., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28496-1 · Cited by 63
Self-citationZhu, C., Huai, Q., Zhang, X., Dai, H., Li, X., & Wang, H. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.78525 · Cited by 59
Adipokines and Adipose Tissue-Related Metabolites, Nuts and Cardiovascular Disease
Weschenfelder, C., de Quadros, A. S., dos Santos, J. L., Garofallo, S. B., & Marcadenti, A. (2020) · Metabolites · doi:10.3390/metabo10010032 · Cited by 58
Sleight, A. G., Crowder, S. L., Skarbinski, J., Coen, P. M., Parker, N. H., Hoogland, A. I., Gonzalez, B. D., Playdon, M. C., Cole, S. W., Ose, J., et al. (2022) · Cancers · doi:10.3390/cancers14081982 · Cited by 63
McGranaghan, P., Saxena, A., Rubens, M., Radenkovic, J., Bach, D., Schleußner, L., Pieske, B. M., Edelmann, F., & Trippel, T. D. (2020) · Biomarkers · doi:10.1080/1354750x.2020.1716073 · Cited by 55
Plasma levels of ceramides relate to ischemic stroke risk and clinical severity
Gui, Y., Li, Q., Liu, L., Zeng, P., Ren, R., Guo, Z., Wang, G., Song, J., & Zhang, P. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.03.009 · Cited by 54
McGranaghan, P., Kirwan, J., García-Rivera, M. A., Pieske, B. M., Edelmann, F., Blaschke, F., Appunni, S., Saxena, A., Rubens, M., Veledar, E., et al. (2021) · Metabolites · doi:10.3390/metabo11090621 · Cited by 55
Global Plasma Metabolomics to Identify Potential Biomarkers of Blood Pressure Progression
Lin, Y., Salihović, S., Fall, T., Hammar, U., Ingelsson, E., Ärnlöv, J., Lind, L., & Sundström, J. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.314356 · Cited by 51
Meeusen, J. W., Donato, L. J., Kopecky, S. L., Vasile, V. C., Jaffe, A. S., & Laaksonen, R. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.10.005 · Cited by 50
Effects of Dicyclohexyl Phthalate Exposure on PXR Activation and Lipid Homeostasis in Mice
Sui, Y., Meng, Z., Chen, J., Liu, J., Hernandez, R., Gonzales, M. B., Gwag, T., Morris, A. J., & Zhou, C. (2021) · Environmental Health Perspectives · doi:10.1289/ehp9262 · Cited by 47
Chen, H., Wang, Z., Qin, M., Zhang, B., Lin, L., Ma, Q., Liu, C., Chen, X., Li, H., Lai, W., et al. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.632950 · Cited by 46
Godny, L., Elial-Fatal, S., Arrouasse, J., Fischler, T. S., Reshef, L., Kutukov, Y., Cohen, S., Pfeffer‐Gik, T., Barkan, R., Shakhman, S. R., et al. (2025) · Gastroenterology · doi:10.1053/j.gastro.2024.12.031 · Cited by 51
Zhao, W., Wang, X., Deik, A., Hanna, D. B., Wang, T., Haberlen, S., Shah, S. J., Lazar, J., Hodis, H. N., LANDAY, A. L., et al. (2019) · Circulation · doi:10.1161/circulationaha.118.037487 · Cited by 46
Self-citationPotential therapeutic targets for atherosclerosis in sphingolipid metabolism
Yu, Z., Peng, Q., & Huang, Y. (2019) · Clinical Science · doi:10.1042/cs20180911 · Cited by 46
Mantovani, A., Bonapace, S., Lunardi, G., Canali, G., Dugo, C., Vinco, G., Calabria, S., Barbieri, E., Laaksonen, R., Bonnet, F., et al. (2019) · Diabetes & Metabolism · doi:10.1016/j.diabet.2019.07.006 · Cited by 46
Chai, J. C., Deik, A., Hua, S., Wang, T., Hanna, D. B., Xue, X., Haberlen, S., Shah, S. J., Suh, Y., Lazar, J., et al. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2019.4025 · Cited by 46
Self-citationNutrients, Physical Activity, and Mitochondrial Dysfunction in the Setting of Metabolic Syndrome
Lemos, G., Torrinhas, R. S., & Waitzberg, D. L. (2023) · Nutrients · doi:10.3390/nu15051217 · Cited by 53
Gaggini, M., Sabatino, L., & Vassalle, C. (2020) · BioTechniques · doi:10.2144/btn-2019-0138 · Cited by 47
Mantovani, A., Lunardi, G., Bonapace, S., Dugo, C., Altomari, A., Molon, G., Conti, A., Bovo, C., Laaksonen, R., Byrne, C. D., et al. (2020) · Diabetes & Metabolism · doi:10.1016/j.diabet.2020.03.003 · Cited by 47
Li, W., Belwal, T., Li, L., Xu, Y., Liu, J., Zou, L., & Luo, Z. (2021) · Food Research International · doi:10.1016/j.foodres.2021.110566 · Cited by 44
Plasma Ceramides Pathophysiology, Measurements, Challenges, and Opportunities
Gaggini, M., Pingitore, A., & Vassalle, C. (2021) · Metabolites · doi:10.3390/metabo11110719 · Cited by 45
Karjalainen, J.-P., Mononen, N., Hutri‐Kähönen, N., Lehtimäki, M., Hilvo, M., Kauhanen, D., Juonala, M., Viikari, J. S. A., Kähönen, M. A. P., Raitakari, O. T., et al. (2019) · Journal of Lipid Research · doi:10.1194/jlr.m092809 · Cited by 43
Insulin resistance in Alzheimer’s disease: The genetics and metabolomics links
Amin, A. M., Mostafa, H. M. A., & Khojah, H. M. J. (2022) · Clinica Chimica Acta · doi:10.1016/j.cca.2022.12.016 · Cited by 45
Jiménez‐González, S., Marín‐Royo, G., Jurado-López, R., Bartolomé, M. V., Romero‐Miranda, A., Luaces, M., Islas, F., Nieto, M. L., Martínez‐Martínez, E., & Cachofeiro, V. (2020) · Cells · doi:10.3390/cells9020451 · Cited by 42
A plasma lipid signature predicts incident coronary artery disease
Ottosson, F. A., Khoonsari, P. E., Gerl, M. J., Simons, K., Melander, O., & Fernandez, C. (2021) · International Journal of Cardiology · doi:10.1016/j.ijcard.2021.01.059 · Cited by 42
Circulating Ceramides and Sphingomyelins and Risk of Mortality: The Cardiovascular Health Study
Fretts, A. M., Jensen, P. N., Hoofnagle, A. N., McKnight, B., Sitlani, C. M., Siscovick, D. S., King, I. B., Psaty, B. M., Sotoodehnia, N., & Lemaître, R. N. (2021) · Clinical Chemistry · doi:10.1093/clinchem/hvab182 · Cited by 41
Plasma sphingolipids and risk of cardiovascular diseases: a large-scale lipidomic analysis
Seah, J. Y. H., Chew, W. S., Torta, F. T., Khoo, C. M., Wenk, M. R., Herr, D. R., Choi, H., Tai, E. S., & van Dam, R. M. (2020) · Metabolomics · doi:10.1007/s11306-020-01709-8 · Cited by 41
Plasma ceramides containing saturated fatty acids are associated with risk of type 2 diabetes
Fretts, A. M., Jensen, P. N., Hoofnagle, A. N., McKnight, B., Howard, B. V., Umans, J. G., Sitlani, C. M., Siscovick, D. S., King, I. B., Djoussé, L., et al. (2021) · Journal of Lipid Research · doi:10.1016/j.jlr.2021.100119 · Cited by 41
The interplay between nonalcoholic fatty liver disease and atherosclerotic cardiovascular disease
Finney, A. C., Das, S., Kumar, D., McKinney, M. P., Cai, B., Yurdagul, A., & Rom, O. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1116861 · Cited by 40
Metabolomics: A useful tool for ischemic stroke research
Li, W., Shao, C., Li, C., Zhou, H., Yu, L., Yang, J., Wan, H., & He, Y. G. (2023) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2023.05.015 · Cited by 41
Paroni, R. C., Dei, M., Rizzo, J., Ghidoni, R., Montagna, M. T., Rubino, F. M., & Iriti, M. (2019) · Journal of Food Composition and Analysis · doi:10.1016/j.jfca.2019.05.010 · Cited by 40
Is There More to Olive Oil than Healthy Lipids?
Isaakidis, A., Maghariki, J. E., Carvalho-Barros, S., Gomes, A., & Correia, M. (2023) · Nutrients · doi:10.3390/nu15163625 · Cited by 51
Mantovani, A., Bonapace, S., Lunardi, G., Salgarello, M., Dugo, C., Gori, S., Barbieri, E., Verlato, G., Laaksonen, R., Byrne, C. D., et al. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.311927 · Cited by 38
Barz, M. L., Vors, C., Combe, E., Joumard‐Cubizolles, L., Lecomte, M., Joffre, F., Trauchessec, M., Pesenti, S., Loizon, E., Breyton, A.-E., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.146161 · Cited by 38
Circulating Ceramides- Are Origins Important for Sphingolipid Biomarkers and Treatments?
Mah, M., Febbraio, M. A., & Turpin-Nolan, S. M. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.684448 · Cited by 40
Associations between plasma ceramides and mortality in patients with coronary artery disease
Li, Q., Wang, X., Pang, J., Zhang, Y., Zhang, H., Xu, Z., Chen, Q., & Ling, W. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2020.09.004 · Cited by 37
Thioesterase-mediated control of cellular calcium homeostasis enables hepatic ER stress
Ersoy, B. A., Maner-Smith, K. M., Li, Y., Alpertunga, I., & Cohen, D. E. (2017) · Journal of Clinical Investigation · doi:10.1172/jci93123 · Cited by 36
Astaxanthin: A promising therapeutic agent for organ fibrosis
Li, K., Wang, W., & Xiao, W. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106657 · Cited by 37
Chen, S., Wu, Q., Zhu, L., Zong, G., Li, H., Zheng, H., Zeng, R., Lin, X., & Sun, L. D. (2021) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqab050 · Cited by 35
Sphingolipids as Biomarkers of Disease
Matanes, F., Twal, W. O., & Hammad, S. M. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-21162-2_7 · Cited by 35
Deng, P., Hoffman, J. B., Petriello, M. C., Wang, C., Li, X., Kraemer, M. P., Morris, A. J., & Hennig, B. (2019) · Journal of Lipid Research · doi:10.1194/jlr.ra119000346 · Cited by 34
Sekikawa, A. M., Cui, C., Sugiyama, D., Fabio, A., Harris, W. S., & Zhang, X. (2019) · Nutrients · doi:10.3390/nu11112599 · Cited by 38
Association between ceramides and coronary artery stenosis in patients with coronary artery disease
Tu, C., Xie, L., Wang, Z., Zhang, L., Wu, H., Ni, W., Li, C., Li, L., & Zeng, Y. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01329-0 · Cited by 34
Plasma Ceramides and Cardiovascular Events in Hypertensive Patients at High Cardiovascular Risk
Yin, W., Li, F., Tan, X., Wang, H., Jiang, W., Wang, X., Li, S., Zhang, Y., Han, Q., Wang, Y., et al. (2021) · American Journal of Hypertension · doi:10.1093/ajh/hpab105 · Cited by 34
Metadata
- Authors
- Wang, D. D., Toledo, E., Hruby, A., Rosner, B. A., Willett, W. C., Sun, Q., Razquin, C., Zheng, Y., Ruiz-Canela, M., Guasch-Ferré, M., Corella, D., Gómez-Gracia, E., Fiol, M., Estruch, R., Ros, E., Lapetra, J., Fito, M., Aros, F., Serra-Majem, L., Lee, C.-H., Clish, C. B., Liang, L., Salas-Salvadó, J., Martínez-González, M. A., & Hu, F. B.
- Affiliations
- Harvard University (US)
- From Department of Nutrition (D.D.W., W.C.W., Q.S., Y.Z., M.G.-F., C.-H.L., F.B.H.); Department of Epidemiology (D.D.W., W.C.W., L.L., F.B.H.), Department of Biostatistics (B.A.R., L.L.), Department of Genetics and Complex Diseases (C.-H.L.), Harvard T.H. Chan School of Public Health, Boston, MA; Department of Nutrition (M.A.M.-G.), Department of Preventive Medicine and Public Health, University of Navarra, Pamplona, Spain (E.T., C.R., M.R.-C., M.A.M.-G.); Instituto de Investigación Sanitaria de...
- ORCID
- Venue
- Circulation
- Published
- 2017-05-23
- Volume
- 135
- Issue
- 21
- Pages
- 2028-2040
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- PMC
- PMC5496817
- OpenAlex
- W2890371182
- Cited by
- 327
- References
- 83
- Citations by year
- 2026: 29 · 2025: 33 · 2024: 30 · 2023: 38 · 2022: 44 · 2021: 50 · 2020: 42 · 2019: 34 · 2018: 21 · 2017: 6
- FWCI
- 11.51
- Type
- journal article
- Language
- en
- Update notices
- correction (2019-10-14)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Rovira & Virgili repository (submittedVersion, cc-by)
- RISalud Institutional Health Repository of Andalucía (submittedVersion, other-oa)
- Acceda (Universidad de Las Palmas de Gran Canaria) (submittedVersion)
- Funders
- U.S. Department of Agriculture
- American Heart Association
- Brigham and Women's Hospital
- Massachusetts Institute of Technology
- Harvard University
- Harvard T.H. Chan School of Public Health
- Universidad de Málaga
- Institut d'Investigació Sanitària Pere Virgili
- Broad Institute
- Generalitat de Catalunya
- Fundación Mapfre (Fundación Mapfre 2010)
- Generalitat Valenciana
- Universitat de València
- Universidad de Navarra
- Ministerio de Ciencia e Innovación
- Universitat de Barcelona
- Centro Nacional de Investigaciones Cardiovasculares
- Universidad de Las Palmas de Gran Canaria
- Universitat Rovira i Virgili
- Junta de Andalucía
- Centro de Investigación Biomédica en Red-Fisiopatología de la Obesidad y Nutrición
- Gobierno de Navarra
- National Institutes of Health
- Instituto de Salud Carlos III
- European Regional Development Fund
- Faculty of Medicine and Health, University of Sydney
- National Heart, Lung, and Blood Institute (R01HL118264)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK040561)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
- Keywords
- plasma ceramides, cardiovascular disease, Mediterranean diet, PREDIMED trial, extra virgin olive oil, nuts, cardiovascular risk, myocardial infarction, stroke, cardiovascular mortality, lipid metabolism, case-cohort design, metabolomics biomarkers
- MeSH terms
- Olive Oil, Aged, Cardiovascular Diseases, Ceramides, Chromatography, Liquid, Female, Humans, Male, Middle Aged, Nuts, Prospective Studies, Risk Factors, Spain, Time Factors, Biomarkers, Incidence, Multivariate Analysis, Linear Models, Proportional Hazards Models, Risk Assessment, Diet, Mediterranean, Risk Reduction Behavior, Tandem Mass Spectrometry, Metabolomics, Protective Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
